News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sawai Pharmaceutical Co., Ltd. To Take Over Three Ethical Products From Nihon Schering K. K.


10/19/2005 5:09:05 PM

Tokyo (JCN) - Sawai Pharmaceutical (TSE: 4555) announced on August 2 that it will take over the production and sales operations for three ethical products from Nihon Schering. They are blood coagulation inhibitor Caprocin Inj., gastrointestinal tract stabilizers Coreminal Tab. and Coreminal Fine granule, and antiparkinson drug Bicamol Tab.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES